Dexamethasone Dosing for Late-Stage ARDS
Introduction to Dexamethasone Dosing
- For late persistent ARDS (after day 6 of onset), the recommended dose is methylprednisolone 2 mg/kg/day, with slow tapering over 13 days, as suggested by the guideline society, although the specific society is not mentioned 1
Patient Selection and Timing
- Active infection should be excluded before initiating corticosteroid therapy, according to the Intensive Care Medicine guidelines 2, 3, 4
Mechanism and Benefits
- Corticosteroid treatment in ARDS is associated with reduction in markers of systemic inflammation, as noted in the Praxis Medical Insights guideline summary 1
Monitoring and Adverse Effects
- Regular monitoring for hyperglycemia is essential, especially within 36 hours following initial treatment, as recommended by the Praxis Medical Insights guideline summary 1
- Abrupt discontinuation of corticosteroids should be avoided as it may lead to deterioration from reconstituted inflammatory response, according to the Praxis Medical Insights guideline summary 1
Important Caveats
- Methylprednisolone may be preferred in some cases due to greater penetration into lung tissue and longer residence time compared to other steroids, as suggested by the Praxis Medical Insights guideline summary 1
- Patients should continue to receive lung-protective ventilation strategies (6 ml/kg predicted body weight) as per ARDS Network protocol, as recommended by the Praxis Medical Insights guideline summary 1
- Corticosteroids should not be routinely administered to patients at risk for, or meeting initial criteria for ALI/ARDS, but should be considered for persistent or refractory cases, according to the Intensive Care Medicine guidelines 2, 3, 4